0.5906
+0.0152
+(2.64%)
At close: January 30 at 7:30:14 PM GMT+1
Key Executives
Key Executives Information Not Available
Mersana Therapeutics Inc
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Mersana Therapeutics Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 26, 2025 at 1:30 PM UTC - March 3, 2025 at 1:30 PM UTC
Mersana Therapeutics Inc Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
M55.F MacroGenics, Inc.
2.8940
-5.67%
NV4.F Cellectar Biosciences, Inc.
0.2000
-9.91%
1VT.DU Viking Therapeutics Inc
32.15
-1.20%
3G0.BE Altimmune Inc
6.71
-0.52%
2UV.DU Applied Therapeutics Inc
0.5745
+2.96%
AT20.F Atara Biotherapeutics, Inc.
7.45
-5.70%
NV4.MU Cellectar Biosciences Inc
0.2420
-3.20%
8AW0.F Ocean Biomedical, Inc.
0.2200
-34.91%
8AW0.BE Ocean Biomedical Inc
0.1810
-23.31%
2UV.F Applied Therapeutics, Inc.
0.5150
-2.00%